Louse-borne relapsing fever is an acute bacterial infection that triggers recurring episodes of high fever. It is caused by the spirochete Borrelia recurrentis, which is a spiral-shaped bacterium ...
Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice). The disease was first described by Hippocrates (460-370 BC).
Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...
Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who ...
Morning Overview on MSN
The first US trials of gene-edited pig kidneys in patients are set to begin
Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...
The concept of trained immunity has redefined innate immune responses as adaptable, durable, and context dependent. Natural killer (NK) cells, traditionally ...
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have ...
Researchers at the University of Sheffield have discovered that a fungus deadly to people with weakened immune systems can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results